Diversion Control Division, US Department of Justice, Drug Enforcement Administration

Manufacturers Notice of Registration - 2001

[Federal Register: December 27, 2001 (Volume 66, Number 248)] [Notices] [Page 66939] From the Federal Register Online via GPO Access [wais.access.gpo.gov] [DOCID:fr27de01-141]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled Substances; Notice of Registration

By Notice dated August 24, 2001, and published in the Federal Register on September 6, 2001, (66 FR 46653), Chattem Chemicals, Inc., 3801 St. Elmo Avenue, Building 18, Chattanooga, Tennessee 37409, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed below:

Drug Schedule
N-Ethylamphetamine (1475) I
4-Methoxyamphetamine (7411) I
2,5-Dimethoxyamphetamine (7396) I
Difenoxin I
Amphetamine (1100) II
Methamphetamine (1105) II
Methylphenidate (1724) II
Pentobarbital (2270) II
Secobarbital (2315) II
Codeine (9050) II
Oxycodone (9143) II
Diphenoxylate (9170) II
Hydrocodone (9193) II
Meperidine (9230) II
Morphine (9300) II
Thebaine (9333) II
Alfentanil (9737) II
Sufentanil (9740) II
Fentanyl (9801) II

The firm plans to bulk manufacture the listed controlled substances to produce products for distribution to its customers. 

No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, Section 823(a) and determined that the registration of Chattem Chemicals, Inc. to manufacture the listed controlled substances is consistent with the public interest at this time. DEA has investigated Chattem Chemicals, Inc. to ensure that the company's registration is consistent with the public interest. This investigation included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history.

Therefore, pursuant to 21 U.S.C. 823 and 28 CFR §§ 0.100 and 0.104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basic classes of controlled substances listed above is granted.

Dated: December 18, 2001.

Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.

[FR Doc. 01-31822 Filed  12-26-01; 8:45 am]

BILLING CODE 4410-09-M

 

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Printing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility